GlassScriptPhysician profile
Kristin J Daniel
NPI 1215127725
$577.49
in general payments reported to CMS, 2019-2025
13 companies · $27.72 in 2025
The $27.72 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2020: $73.51 · 2021: $12.82 · 2022: $35.56 · 2024: $15.76 · 2025: $27.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $43.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $43.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $172.17 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $112.89 | 2019-2020 | |
| Duchesnay USA Incorporated | $85.72 | 2019 | |
| Mylan Pharmaceuticals INC. | $47.15 | 2019-2020 | |
| Coopersurgical, INC. | $31.00 | 2019-2024 | Paragard T 380a |
| Johnson & Johnson Vision Care, INC. | $27.72 | 2025 | |
| Hologic Sales and Service, LLC | $17.89 | 2019 | |
| Therapeuticsmd, INC. | $16.31 | 2019 | |
| Lupin INC. | $15.12 | 2019 | |
| Daiichi Sankyo INC. | $14.82 | 2019 | |
| Avion Pharmaceuticals | $14.26 | 2020 | |
| Exeltis, USA INC. | $11.57 | 2019 | |
| Merck Sharp & Dohme LLC | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Daniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.